|
KCTD21 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.087800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.086200E-01 |
| Normal-vs-Stage2 |
4.259400E-01 |
| Normal-vs-Stage3 |
1.937840E-02 |
| Normal-vs-Stage4 |
6.939400E-03 |
| Stage1-vs-Stage2 |
8.434400E-01 |
| Stage1-vs-Stage3 |
7.752400E-02 |
| Stage1-vs-Stage4 |
3.423800E-02 |
| Stage2-vs-Stage3 |
1.792240E-01 |
| Stage2-vs-Stage4 |
7.267500E-02 |
| Stage3-vs-Stage4 |
4.877400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.704500E-02 |
| Normal-vs-AfricanAmerican |
1.699650E-01 |
| Normal-vs-Asian |
9.057800E-01 |
| Caucasian-vs-AfricanAmerican |
8.141600E-01 |
| Caucasian-vs-Asian |
1.099380E-01 |
| AfricanAmerican-vs-Asian |
1.974210E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.256300E-03 |
| Normal-vs-Female |
2.269000E-01 |
| Male-vs-Female |
3.456400E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.187000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.484500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.360150E-02 |
| Normal-vs-Age(81-100Yrs) |
5.482000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.200400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.903600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.186430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.665010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.277600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.275000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.292010E-01 |
| Classical-VS-Follicular |
1.434000E-02 |
| Classical-VS-Other |
6.304000E-02 |
| Classical-VS-Normal |
3.152800E-01 |
| Tall-VS-Follicular |
9.035600E-01 |
| Tall-VS-Other |
2.463200E-01 |
| Tall-VS-Normal |
4.563700E-02 |
| Follicular-VS-Other |
3.752400E-01 |
| Follicular-VS-Normal |
1.747780E-02 |
| Other-VS-Normal |
3.164500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.204200E-02 |
| Normal-vs-N1 |
2.231900E-02 |
| N0-vs-N1 |
3.466000E-01 |
|
|
